HB2657 creates a new Virginia involuntary manslaughter offense for a person who knowingly and intentionally manufactures, sells, or distributes a controlled substance containing a detectable amount of fentanyl, and whose conduct unintentionally causes another person’s death. The death must result from use of the drug, and fentanyl must be the proximate cause of death. The bill also specifies that a victim’s voluntary use of the drug is not a defense, and it sets venue in the locality where the drug transaction, use, or death occurred.
The bill also amends Virginia’s overdose immunity law. It expands the list of offenses for which a person generally may not be arrested or prosecuted when they in good faith seek emergency medical help for an overdose, including the new fentanyl-related involuntary manslaughter offense. The immunity applies when a person calls for help, remains at the scene, identifies themselves to law enforcement, and the evidence was obtained because of the overdose report. The bill preserves exceptions for searches, warrants, and arrests, and it protects officers from false-arrest liability when acting in good faith.
Impact
HB2657 amends the criminal code by adding a fentanyl-specific involuntary manslaughter statute and revising the overdose Good Samaritan protections in § 18.2-251.03. It affects drug distribution offenses under Article 1 of Chapter 7, homicide liability, venue rules, and related prosecution limits, while also creating a carve-out for accommodation transfers that are not for profit or to induce addiction. The bill is expected to increase incarceration or commitment costs, and the fiscal note states the impact cannot be precisely estimated, requiring a minimum appropriation assumption.
Sentiment
The bill appears to have broad support overall, but not unanimous support, based on strong committee and floor votes in both chambers and the eventual conference report agreement. At the same time, the recorded votes show some sustained opposition, especially during the House’s rejection of the Senate substitute and the close 47-46 vote on a later adoption motion. That pattern suggests general agreement with the bill’s anti-fentanyl objective, alongside disagreement over the final wording or scope of the immunity and criminal liability provisions.
Contention
The main points of contention appear to be the breadth of criminal liability for fentanyl-related deaths and how the new offense interacts with overdose reporting protections. Supporters likely favored stronger accountability for fentanyl distribution, while opponents may have been concerned about overcriminalization, proof issues around proximate cause, and whether the law could discourage people from calling 911 in overdose situations. The accommodation-sale exception and the immunity carve-outs also suggest debate over distinguishing low-level sharing from profit-driven distribution and balancing enforcement with public-health-oriented overdose response.
Controlled substances: penalties; conduct associated with qualified psychoactive substances; exempt from criminal penalties in certain circumstances. Amends secs. 7401, 7403 & 7404 of 1978 PA 368 (MCL 333.7401 et seq.).
Drug Testing for Welfare Recipients Act This bill requires the Temporary Assistance for Needy Families program, the Supplemental Nutrition Assistance Program, and specified public housing programs to subject individuals to substance-abuse screening and to deny benefits for individuals who test positive for a controlled substance.